MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

100 mcg/0.3 mL injection syringe

• Inject 0.3 milliliter (100 mcg) by subcutaneous route once a month inthe abdomen, thigh, or outer area of upper arm (rotate sites)

150 mcg/0.3 mL injection syringe

• Inject 0.3 milliliter (150 mcg) by subcutaneous route once a month inthe abdomen, thigh, or outer area of upper arm (rotate sites)

200 mcg/0.3 mL injection syringe

• Inject 0.3 milliliter (200 mcg) by subcutaneous route once a month inthe abdomen, thigh, or outer area of upper arm (rotate sites)

30 mcg/0.3 mL injection syringe

• Inject 0.3 milliliter (30 mcg) by subcutaneous route once a month in the abdomen, thigh, or outer area of upper arm (rotate sites)

50 mcg/0.3 mL injection syringe

• Inject 0.3 milliliter (50 mcg) by subcutaneous route once a month in the abdomen, thigh, or outer area of upper arm (rotate sites)

75 mcg/0.3 mL injection syringe

• Inject 0.3 milliliter (75 mcg) by subcutaneous route once a month in the abdomen, thigh, or outer area of upper arm (rotate sites)

Anemia in chronic kidney disease

• Inject 0.6 mcg/kg by intravenous route every 2 weeks

• Inject 0.6 mcg/kg by intravenous route once a month

• Inject 0.3 milliliter (30 mcg) by intravenous route every 2 weeks

• Inject 0.3 milliliter (30 mcg) by intravenous route once a month

• Inject 0.3 milliliter (30 mcg) by subcutaneous route every 2 weeks inthe abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (30 mcg) by subcutaneous route once a month in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (50 mcg) by intravenous route every 2 weeks

• Inject 0.3 milliliter (50 mcg) by intravenous route once a month

• Inject 0.3 milliliter (50 mcg) by subcutaneous route every 2 weeks inthe abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (50 mcg) by subcutaneous route once a month in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (75 mcg) by intravenous route every 2 weeks

• Inject 0.3 milliliter (75 mcg) by intravenous route once a month

• Inject 0.3 milliliter (75 mcg) by subcutaneous route every 2 weeks inthe abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (75 mcg) by subcutaneous route once a month in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (100 mcg) by intravenous route every 2 weeks

• Inject 0.3 milliliter (100 mcg) by intravenous route once a month

• Inject 0.3 milliliter (100 mcg) by subcutaneous route every 2 weeks in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (100 mcg) by subcutaneous route once a month inthe abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (150 mcg) by intravenous route every 2 weeks

• Inject 0.3 milliliter (150 mcg) by subcutaneous route once a month inthe abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (150 mcg) by subcutaneous route every 2 weeks in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (150 mcg) by intravenous route once a month

• Inject 0.3 milliliter (200 mcg) by subcutaneous route once a month inthe abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 0.3 milliliter (200 mcg) by intravenous route once a month

• Inject 0.6 mcg/kg by subcutaneous route every 2 weeks in the abdomen,thigh, or outer area of upper arm (rotate sites)

• Inject 0.6 mcg/kg by subcutaneous route once a month in the abdomen, thigh, or outer area of upper arm (rotate sites)